{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:56:41Z","timestamp":1760147801151,"version":"build-2065373602"},"reference-count":21,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Individuals with Lyme disease can be very symptomatic. This survey compares the burden of illness for individuals with a history of Lyme disease (HLD) with individuals with a HLD who have either contracted COVID-19 or who have taken the COVID-19 vaccine. The findings describe the relative symptom burden among these three groups using a cross-sectional descriptive survey investigating the burden of Lyme disease in a pandemic. The survey includes the General Symptom Questionnaire-30 (GSQ-30), a brief self-report scale designed to assess the symptom burden in Lyme disease (LD). The results of this survey show that the overall burden of illness among individuals with HLD is not significantly different after contracting COVID-19 or after COVID-19 vaccination. A new survey will be needed to better understand why one in five individuals with a HLD reported long COVID after contracting COVID-19. These results should help clinicians and their patients to discuss the consequences of contracting a COVID-19 infection or being vaccinated against COVID-19.<\/jats:p>","DOI":"10.3390\/antibiotics12030493","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T03:29:00Z","timestamp":1677727740000},"page":"493","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Consequences of Contracting COVID-19 or Taking the COVID-19 Vaccine for Individuals with a History of Lyme Disease"],"prefix":"10.3390","volume":"12","author":[{"given":"Daniel J.","family":"Cameron","sequence":"first","affiliation":[{"name":"Northern Westchester Hospital, Mt. Kisco, New York, NY 10549, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2029-810X","authenticated-orcid":false,"given":"Sean R.","family":"McWhinney","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Dalhousie University, Halifax, NS B3H 2E2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease","volume":"323","author":"Logigian","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1212\/WNL.37.11.1700","article-title":"Lyme disease: Cause of a treatable peripheral neuropathy","volume":"37","author":"Halperin","year":"1987","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1176\/ajp.151.11.1571","article-title":"Lyme disease: A neuropsychiatric illness","volume":"151","author":"Fallon","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neubiorev.2018.01.001","article-title":"Treatment of PANDAS and PANS: A systematic review","volume":"86","author":"Sigra","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ajpath.2015.12.027","article-title":"Cardiac Tropism of Borrelia burgdorferi: An Autopsy Study of Sudden Cardiac Death Associated with Lyme Carditis","volume":"186","author":"Muehlenbachs","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_7","first-page":"63","article-title":"Postural orthostatic tachycardia syndrome following Lyme disease","volume":"18","author":"Kanjwal","year":"2011","journal-title":"Cardiol. J."},{"key":"ref_8","first-page":"e18703","article-title":"Post-Treatment Lyme Disease Syndrome: Need for Diagnosis and Treatment","volume":"13","author":"Maksimyan","year":"2021","journal-title":"Cureus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fmed.2019.00283","article-title":"The General Symptom Questionnaire-30 (GSQ-30): A Brief Measure of Multi-System Symptom Burden in Lyme Disease","volume":"6","author":"Fallon","year":"2019","journal-title":"Front. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/09084280802324473","article-title":"Memory and executive functions in adolescents with posttreatment Lyme disease","volume":"15","author":"McAuliffe","year":"2008","journal-title":"Appl. Neuropsychol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/314860","article-title":"Successful treatment of Lyme encephalopathy with intravenous ceftriaxone","volume":"180","author":"Logigian","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): A randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/01410768211032850","article-title":"Symptoms, complications and management of long COVID: A review","volume":"114","author":"Aiyegbusi","year":"2021","journal-title":"J. R. Soc. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"n1648","DOI":"10.1136\/bmj.n1648","article-title":"Long covid-mechanisms, risk factors, and management","volume":"374","author":"Crook","year":"2021","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sanchez-Ramirez, D.C., Normand, K., Zhaoyun, Y., and Torres-Castro, R. (2021). Long-Term Impact of COVID-19: A Systematic Review of the Literature and Meta-Analysis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080900"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajic.2021.10.015","article-title":"The safety profile of COVID-19 vaccinations in the United States","volume":"50","author":"Singh","year":"2022","journal-title":"Am. J. Infect. Control"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting Linear Mixed-Effects Models Using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"key":"ref_19","unstructured":"Lenth, R.V. (2022, January 01). Emmeans: Estimated Marginal Means, Aka Least-Squares Means. Available online: https:\/\/CRAN.R-project.org\/package=emmeans."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","article-title":"Symptoms and risk factors for long COVID in non-hospitalized adults","volume":"28","author":"Subramanian","year":"2022","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/CVI.00071-16","article-title":"CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: A Prospective Clinical Cohort Study","volume":"23","author":"Aucott","year":"2016","journal-title":"Clin. Vaccine Immunol."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/3\/493\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:45:13Z","timestamp":1760121913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/3\/493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["antibiotics12030493"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics12030493","relation":{},"ISSN":["2079-6382"],"issn-type":[{"type":"electronic","value":"2079-6382"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}